img

Global Covid-19 Therapeutic Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Covid-19 Therapeutic Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Covid-19 Therapeutic Market
Global Covid-19 Therapeutic market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2023 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Covid-19 Therapeutic industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2023, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2023. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2023. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Covid-19 Therapeutic market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Covid-19 Therapeutic market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
AstraZeneca
Cipla
AbbVie
Bayer
Regeneron Pharmaceuticals
Ascletis Pharma
GlaxoSmithKline
Gilead Sciences
Pharmstandard
Fujifilm Holdings
Zhejiang Hisun Pharmaceutical Co. Ltd
Roche
Sanofi
Pfizer
Segment by Type
Immunotherapy
Life Support
Antiviral Medicine
Plasma Therapy
Others

Segment by Application


Children
Adult
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Covid-19 Therapeutic introduction, etc. Covid-19 Therapeutic Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRA Research’s Conclusions of Covid-19 Therapeutic
Chapter 13Methodology and Data Sources adopted by MRA Research

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Therapeutic Market Size Growth Rate by Type, 2018 VS 2023 VS 2033
1.2.2 Immunotherapy
1.2.3 Life Support
1.2.4 Antiviral Medicine
1.2.5 Plasma Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Covid-19 Therapeutic Market Size Growth Rate by Application, 2018 VS 2023 VS 2033
1.3.2 Children
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Therapeutic Market Perspective (2018-2033)
2.2 Global Covid-19 Therapeutic Growth Trends by Region
2.2.1 Covid-19 Therapeutic Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Covid-19 Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Covid-19 Therapeutic Forecasted Market Size by Region (2024-2033)
2.3 Covid-19 Therapeutic Market Dynamics
2.3.1 Covid-19 Therapeutic Industry Trends
2.3.2 Covid-19 Therapeutic Market Drivers
2.3.3 Covid-19 Therapeutic Market Challenges
2.3.4 Covid-19 Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Covid-19 Therapeutic by Players
3.1.1 Global Covid-19 Therapeutic Revenue by Players (2018-2023)
3.1.2 Global Covid-19 Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Covid-19 Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Covid-19 Therapeutic, Ranking by Revenue, 2021 VS 2023 VS 2023
3.4 Global Covid-19 Therapeutic Market Concentration Ratio
3.4.1 Global Covid-19 Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Therapeutic Revenue in 2023
3.5 Global Key Players of Covid-19 Therapeutic Head office and Area Served
3.6 Global Key Players of Covid-19 Therapeutic, Product and Application
3.7 Global Key Players of Covid-19 Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Therapeutic Breakdown Data by Type
4.1 Global Covid-19 Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Covid-19 Therapeutic Forecasted Market Size by Type (2024-2033)
5 Covid-19 Therapeutic Breakdown Data by Application
5.1 Global Covid-19 Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Covid-19 Therapeutic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Covid-19 Therapeutic Market Size (2018-2033)
6.2 North America Covid-19 Therapeutic Market Size by Type
6.2.1 North America Covid-19 Therapeutic Market Size by Type (2018-2023)
6.2.2 North America Covid-19 Therapeutic Market Size by Type (2024-2033)
6.2.3 North America Covid-19 Therapeutic Market Share by Type (2018-2033)
6.3 North America Covid-19 Therapeutic Market Size by Application
6.3.1 North America Covid-19 Therapeutic Market Size by Application (2018-2023)
6.3.2 North America Covid-19 Therapeutic Market Size by Application (2024-2033)
6.3.3 North America Covid-19 Therapeutic Market Share by Application (2018-2033)
6.4 North America Covid-19 Therapeutic Market Size by Country
6.4.1 North America Covid-19 Therapeutic Market Size by Country: 2018 VS 2023 VS 2033
6.4.2 North America Covid-19 Therapeutic Market Size by Country (2018-2023)
6.4.3 North America Covid-19 Therapeutic Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Covid-19 Therapeutic Market Size (2018-2033)
7.2 Europe Covid-19 Therapeutic Market Size by Type
7.2.1 Europe Covid-19 Therapeutic Market Size by Type (2018-2023)
7.2.2 Europe Covid-19 Therapeutic Market Size by Type (2024-2033)
7.2.3 Europe Covid-19 Therapeutic Market Share by Type (2018-2033)
7.3 Europe Covid-19 Therapeutic Market Size by Application
7.3.1 Europe Covid-19 Therapeutic Market Size by Application (2018-2023)
7.3.2 Europe Covid-19 Therapeutic Market Size by Application (2024-2033)
7.3.3 Europe Covid-19 Therapeutic Market Share by Application (2018-2033)
7.4 Europe Covid-19 Therapeutic Market Size by Country
7.4.1 Europe Covid-19 Therapeutic Market Size by Country: 2018 VS 2023 VS 2033
7.4.2 Europe Covid-19 Therapeutic Market Size by Country (2018-2023)
7.4.3 Europe Covid-19 Therapeutic Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Covid-19 Therapeutic Market Size (2018-2033)
8.2 China Covid-19 Therapeutic Market Size by Type
8.2.1 China Covid-19 Therapeutic Market Size by Type (2018-2023)
8.2.2 China Covid-19 Therapeutic Market Size by Type (2024-2033)
8.2.3 China Covid-19 Therapeutic Market Share by Type (2018-2033)
8.3 China Covid-19 Therapeutic Market Size by Application
8.3.1 China Covid-19 Therapeutic Market Size by Application (2018-2023)
8.3.2 China Covid-19 Therapeutic Market Size by Application (2024-2033)
8.3.3 China Covid-19 Therapeutic Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Covid-19 Therapeutic Market Size (2018-2033)
9.2 Asia Covid-19 Therapeutic Market Size by Type
9.2.1 Asia Covid-19 Therapeutic Market Size by Type (2018-2023)
9.2.2 Asia Covid-19 Therapeutic Market Size by Type (2024-2033)
9.2.3 Asia Covid-19 Therapeutic Market Share by Type (2018-2033)
9.3 Asia Covid-19 Therapeutic Market Size by Application
9.3.1 Asia Covid-19 Therapeutic Market Size by Application (2018-2023)
9.3.2 Asia Covid-19 Therapeutic Market Size by Application (2024-2033)
9.3.3 Asia Covid-19 Therapeutic Market Share by Application (2018-2033)
9.4 Asia Covid-19 Therapeutic Market Size by Region
9.4.1 Asia Covid-19 Therapeutic Market Size by Region: 2018 VS 2023 VS 2033
9.4.2 Asia Covid-19 Therapeutic Market Size by Region (2018-2023)
9.4.3 Asia Covid-19 Therapeutic Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Type
10.2.1 Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Covid-19 Therapeutic Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Application
10.3.1 Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Covid-19 Therapeutic Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Country
10.4.1 Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Country: 2018 VS 2023 VS 2033
10.4.2 Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Cadila Healthcare
11.1.1 Cadila Healthcare Company Details
11.1.2 Cadila Healthcare Business Overview
11.1.3 Cadila Healthcare Covid-19 Therapeutic Introduction
11.1.4 Cadila Healthcare Revenue in Covid-19 Therapeutic Business (2018-2023)
11.1.5 Cadila Healthcare Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Covid-19 Therapeutic Introduction
11.2.4 Johnson & Johnson Revenue in Covid-19 Therapeutic Business (2018-2023)
11.2.5 Johnson & Johnson Recent Developments
11.3 ImmunoPrecise
11.3.1 ImmunoPrecise Company Details
11.3.2 ImmunoPrecise Business Overview
11.3.3 ImmunoPrecise Covid-19 Therapeutic Introduction
11.3.4 ImmunoPrecise Revenue in Covid-19 Therapeutic Business (2018-2023)
11.3.5 ImmunoPrecise Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Covid-19 Therapeutic Introduction
11.4.4 Novartis Revenue in Covid-19 Therapeutic Business (2018-2023)
11.4.5 Novartis Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Covid-19 Therapeutic Introduction
11.5.4 AstraZeneca Revenue in Covid-19 Therapeutic Business (2018-2023)
11.5.5 AstraZeneca Recent Developments
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Covid-19 Therapeutic Introduction
11.6.4 Cipla Revenue in Covid-19 Therapeutic Business (2018-2023)
11.6.5 Cipla Recent Developments
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Covid-19 Therapeutic Introduction
11.7.4 AbbVie Revenue in Covid-19 Therapeutic Business (2018-2023)
11.7.5 AbbVie Recent Developments
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Covid-19 Therapeutic Introduction
11.8.4 Bayer Revenue in Covid-19 Therapeutic Business (2018-2023)
11.8.5 Bayer Recent Developments
11.9 Regeneron Pharmaceuticals
11.9.1 Regeneron Pharmaceuticals Company Details
11.9.2 Regeneron Pharmaceuticals Business Overview
11.9.3 Regeneron Pharmaceuticals Covid-19 Therapeutic Introduction
11.9.4 Regeneron Pharmaceuticals Revenue in Covid-19 Therapeutic Business (2018-2023)
11.9.5 Regeneron Pharmaceuticals Recent Developments
11.10 Ascletis Pharma
11.10.1 Ascletis Pharma Company Details
11.10.2 Ascletis Pharma Business Overview
11.10.3 Ascletis Pharma Covid-19 Therapeutic Introduction
11.10.4 Ascletis Pharma Revenue in Covid-19 Therapeutic Business (2018-2023)
11.10.5 Ascletis Pharma Recent Developments
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Covid-19 Therapeutic Introduction
11.11.4 GlaxoSmithKline Revenue in Covid-19 Therapeutic Business (2018-2023)
11.11.5 GlaxoSmithKline Recent Developments
11.12 Gilead Sciences
11.12.1 Gilead Sciences Company Details
11.12.2 Gilead Sciences Business Overview
11.12.3 Gilead Sciences Covid-19 Therapeutic Introduction
11.12.4 Gilead Sciences Revenue in Covid-19 Therapeutic Business (2018-2023)
11.12.5 Gilead Sciences Recent Developments
11.13 Pharmstandard
11.13.1 Pharmstandard Company Details
11.13.2 Pharmstandard Business Overview
11.13.3 Pharmstandard Covid-19 Therapeutic Introduction
11.13.4 Pharmstandard Revenue in Covid-19 Therapeutic Business (2018-2023)
11.13.5 Pharmstandard Recent Developments
11.14 Fujifilm Holdings
11.14.1 Fujifilm Holdings Company Details
11.14.2 Fujifilm Holdings Business Overview
11.14.3 Fujifilm Holdings Covid-19 Therapeutic Introduction
11.14.4 Fujifilm Holdings Revenue in Covid-19 Therapeutic Business (2018-2023)
11.14.5 Fujifilm Holdings Recent Developments
11.15 Zhejiang Hisun Pharmaceutical Co. Ltd
11.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
11.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview
11.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Introduction
11.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Therapeutic Business (2018-2023)
11.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments
11.16 Roche
11.16.1 Roche Company Details
11.16.2 Roche Business Overview
11.16.3 Roche Covid-19 Therapeutic Introduction
11.16.4 Roche Revenue in Covid-19 Therapeutic Business (2018-2023)
11.16.5 Roche Recent Developments
11.17 Sanofi
11.17.1 Sanofi Company Details
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Covid-19 Therapeutic Introduction
11.17.4 Sanofi Revenue in Covid-19 Therapeutic Business (2018-2023)
11.17.5 Sanofi Recent Developments
11.18 Pfizer
11.18.1 Pfizer Company Details
11.18.2 Pfizer Business Overview
11.18.3 Pfizer Covid-19 Therapeutic Introduction
11.18.4 Pfizer Revenue in Covid-19 Therapeutic Business (2018-2023)
11.18.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Covid-19 Therapeutic Market Size Growth Rate by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Life Support
Table 4. Key Players of Antiviral Medicine
Table 5. Key Players of Plasma Therapy
Table 6. Key Players of Others
Table 7. Global Covid-19 Therapeutic Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 8. Global Covid-19 Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 9. Global Covid-19 Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Covid-19 Therapeutic Market Share by Region (2018-2023)
Table 11. Global Covid-19 Therapeutic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Covid-19 Therapeutic Market Share by Region (2024-2033)
Table 13. Covid-19 Therapeutic Market Trends
Table 14. Covid-19 Therapeutic Market Drivers
Table 15. Covid-19 Therapeutic Market Challenges
Table 16. Covid-19 Therapeutic Market Restraints
Table 17. Global Covid-19 Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Covid-19 Therapeutic Revenue Share by Players (2018-2023)
Table 19. Global Top Covid-19 Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Therapeutic as of 2023)
Table 20. Global Covid-19 Therapeutic Industry Ranking 2021 VS 2023 VS 2023
Table 21. Global 5 Largest Players Market Share by Covid-19 Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Covid-19 Therapeutic, Headquarters and Area Served
Table 23. Global Key Players of Covid-19 Therapeutic, Product and Application
Table 24. Global Key Players of Covid-19 Therapeutic, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Covid-19 Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Covid-19 Therapeutic Revenue Market Share by Type (2018-2023)
Table 28. Global Covid-19 Therapeutic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Covid-19 Therapeutic Revenue Market Share by Type (2024-2033)
Table 30. Global Covid-19 Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Covid-19 Therapeutic Revenue Share by Application (2018-2023)
Table 32. Global Covid-19 Therapeutic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Covid-19 Therapeutic Revenue Share by Application (2024-2033)
Table 34. North America Covid-19 Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Covid-19 Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America Covid-19 Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Covid-19 Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America Covid-19 Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 39. North America Covid-19 Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Covid-19 Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe Covid-19 Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Covid-19 Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe Covid-19 Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Covid-19 Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe Covid-19 Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 46. Europe Covid-19 Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Covid-19 Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 48. China Covid-19 Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Covid-19 Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 50. China Covid-19 Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Covid-19 Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia Covid-19 Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Covid-19 Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia Covid-19 Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Covid-19 Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia Covid-19 Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 57. Asia Covid-19 Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Covid-19 Therapeutic Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Covid-19 Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 64. Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 66. Cadila Healthcare Company Details
Table 67. Cadila Healthcare Business Overview
Table 68. Cadila Healthcare Covid-19 Therapeutic Product
Table 69. Cadila Healthcare Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 70. Cadila Healthcare Recent Developments
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Covid-19 Therapeutic Product
Table 74. Johnson & Johnson Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 75. Johnson & Johnson Recent Developments
Table 76. ImmunoPrecise Company Details
Table 77. ImmunoPrecise Business Overview
Table 78. ImmunoPrecise Covid-19 Therapeutic Product
Table 79. ImmunoPrecise Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 80. ImmunoPrecise Recent Developments
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Covid-19 Therapeutic Product
Table 84. Novartis Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 85. Novartis Recent Developments
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Covid-19 Therapeutic Product
Table 89. AstraZeneca Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 90. AstraZeneca Recent Developments
Table 91. Cipla Company Details
Table 92. Cipla Business Overview
Table 93. Cipla Covid-19 Therapeutic Product
Table 94. Cipla Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 95. Cipla Recent Developments
Table 96. AbbVie Company Details
Table 97. AbbVie Business Overview
Table 98. AbbVie Covid-19 Therapeutic Product
Table 99. AbbVie Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 100. AbbVie Recent Developments
Table 101. Bayer Company Details
Table 102. Bayer Business Overview
Table 103. Bayer Covid-19 Therapeutic Product
Table 104. Bayer Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 105. Bayer Recent Developments
Table 106. Regeneron Pharmaceuticals Company Details
Table 107. Regeneron Pharmaceuticals Business Overview
Table 108. Regeneron Pharmaceuticals Covid-19 Therapeutic Product
Table 109. Regeneron Pharmaceuticals Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 110. Regeneron Pharmaceuticals Recent Developments
Table 111. Ascletis Pharma Company Details
Table 112. Ascletis Pharma Business Overview
Table 113. Ascletis Pharma Covid-19 Therapeutic Product
Table 114. Ascletis Pharma Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 115. Ascletis Pharma Recent Developments
Table 116. GlaxoSmithKline Company Details
Table 117. GlaxoSmithKline Business Overview
Table 118. GlaxoSmithKline Covid-19 Therapeutic Product
Table 119. GlaxoSmithKline Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 120. GlaxoSmithKline Recent Developments
Table 121. Gilead Sciences Company Details
Table 122. Gilead Sciences Business Overview
Table 123. Gilead Sciences Covid-19 Therapeutic Product
Table 124. Gilead Sciences Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 125. Gilead Sciences Recent Developments
Table 126. Pharmstandard Company Details
Table 127. Pharmstandard Business Overview
Table 128. Pharmstandard Covid-19 Therapeutic Product
Table 129. Pharmstandard Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 130. Pharmstandard Recent Developments
Table 131. Fujifilm Holdings Company Details
Table 132. Fujifilm Holdings Business Overview
Table 133. Fujifilm Holdings Covid-19 Therapeutic Product
Table 134. Fujifilm Holdings Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 135. Fujifilm Holdings Recent Developments
Table 136. Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
Table 137. Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview
Table 138. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Product
Table 139. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 140. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments
Table 141. Roche Company Details
Table 142. Roche Business Overview
Table 143. Roche Covid-19 Therapeutic Product
Table 144. Roche Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 145. Roche Recent Developments
Table 146. Sanofi Company Details
Table 147. Sanofi Business Overview
Table 148. Sanofi Covid-19 Therapeutic Product
Table 149. Sanofi Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 150. Sanofi Recent Developments
Table 151. Pfizer Company Details
Table 152. Pfizer Business Overview
Table 153. Pfizer Covid-19 Therapeutic Product
Table 154. Pfizer Revenue in Covid-19 Therapeutic Business (2018-2023) & (US$ Million)
Table 155. Pfizer Recent Developments
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Covid-19 Therapeutic Market Size Growth Rate by Type, 2018 VS 2023 VS 2033 (US$ Million)
Figure 2. Global Covid-19 Therapeutic Market Share by Type: 2023 VS 2033
Figure 3. Immunotherapy Features
Figure 4. Life Support Features
Figure 5. Antiviral Medicine Features
Figure 6. Plasma Therapy Features
Figure 7. Others Features
Figure 8. Global Covid-19 Therapeutic Market Size Growth Rate by Application, 2018 VS 2023 VS 2033 (US$ Million)
Figure 9. Global Covid-19 Therapeutic Market Share by Application: 2023 VS 2033
Figure 10. Children Case Studies
Figure 11. Adult Case Studies
Figure 12. Covid-19 Therapeutic Report Years Considered
Figure 13. Global Covid-19 Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Covid-19 Therapeutic Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 15. Global Covid-19 Therapeutic Market Share by Region: 2023 VS 2033
Figure 16. Global Covid-19 Therapeutic Market Share by Players in 2023
Figure 17. Global Top Covid-19 Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Therapeutic as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Covid-19 Therapeutic Revenue in 2023
Figure 19. North America Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Covid-19 Therapeutic Market Share by Type (2018-2033)
Figure 21. North America Covid-19 Therapeutic Market Share by Application (2018-2033)
Figure 22. North America Covid-19 Therapeutic Market Share by Country (2018-2033)
Figure 23. United States Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Covid-19 Therapeutic Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Covid-19 Therapeutic Market Share by Type (2018-2033)
Figure 27. Europe Covid-19 Therapeutic Market Share by Application (2018-2033)
Figure 28. Europe Covid-19 Therapeutic Market Share by Country (2018-2033)
Figure 29. Germany Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Covid-19 Therapeutic Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Covid-19 Therapeutic Market Share by Type (2018-2033)
Figure 37. China Covid-19 Therapeutic Market Share by Application (2018-2033)
Figure 38. Asia Covid-19 Therapeutic Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Covid-19 Therapeutic Market Share by Type (2018-2033)
Figure 40. Asia Covid-19 Therapeutic Market Share by Application (2018-2033)
Figure 41. Asia Covid-19 Therapeutic Market Share by Region (2018-2033)
Figure 42. Japan Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Covid-19 Therapeutic Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Covid-19 Therapeutic Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Covid-19 Therapeutic Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Covid-19 Therapeutic Market Share by Country (2018-2033)
Figure 52. Brazil Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Covid-19 Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Cadila Healthcare Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 59. Johnson & Johnson Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 60. ImmunoPrecise Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 61. Novartis Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 62. AstraZeneca Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 63. Cipla Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 64. AbbVie Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 65. Bayer Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 66. Regeneron Pharmaceuticals Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 67. Ascletis Pharma Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 68. GlaxoSmithKline Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 69. Gilead Sciences Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 70. Pharmstandard Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 71. Fujifilm Holdings Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 72. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 73. Roche Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 74. Sanofi Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 75. Pfizer Revenue Growth Rate in Covid-19 Therapeutic Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries